Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexi Vasbinder

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
JACC. Cardiooncology|May 2, 2022
Lifestyle and Cardiovascular Risk Factors Associated With Heart Failure Subtypes in Postmenopausal Breast Cancer SurvivorsKerryn W Reding, Richard K Cheng, Alexi Vasbinder, et al.
JACC. Cardiooncology|October 31, 2024
Life's Essential 8 and Incident Cardiovascular Disease in U.S. Women With Breast CancerElena Wadden, Alexi Vasbinder, Vidhushei Yogeswaran, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 27, 2024
Biomarkers of chronic inflammation and cognitive decline: A prospective observational studyBhavna A Guduguntla, Alexi Vasbinder, Elizabeth Anderson, et al.
Journal of Cardiovascular Translational Research|September 30, 2022
Chronic Oxidative Stress as a Marker of Long-term Radiation-Induced Cardiovascular Outcomes in Breast CancerAlexi Vasbinder, Richard K Cheng, Susan R Heckbert, et al.
The American Journal of Clinical Nutrition|December 31, 2020
Risk of metabolic syndrome and metabolic phenotypes in relation to biomarker-calibrated estimates of energy and protein intakes: an investigation from the Women's Health InitiativeAlexi Vasbinder, Lesley F Tinker, Marian L Neuhouser, et al.
The American Journal of Medicine|August 23, 2024
Statin Therapy, Inflammation, and Outcomes in Patients Hospitalized for COVID-19: A Prospective Multicenter Cohort StudyAnis Ismail, Husam R Shadid, Yiyuan Huang, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2026
Impact of <sup>18</sup> FDG-avidity and immunosuppression on idiopathic and genetic cardiomyopathiesShiva Tabaghi, Graham H Bevan, Stephen Hankinson, et al.
Journal of the American Heart Association|December 27, 2024
Inflammatory Markers and Measures of Cardiovascular Autonomic Neuropathy in Type 1 DiabetesLynn Ang, Sejal Gunaratnam, Yiyuan Huang, et al.
Journal of Cardiac Failure|March 2, 2026
Sotagliflozin, suPAR, and Cardiovascular Outcomes in Patients with Diabetes and Heart Failure: A SOLOIST-WHF Ancillary StudyAnis Ismail, Grace Erne, Alexi Vasbinder, et al.
Circulation. Cardiovascular Quality and Outcomes|October 4, 2022
Relationship Between Preexisting Cardiovascular Disease and Death and Cardiovascular Outcomes in Critically Ill Patients With COVID-19Alexi Vasbinder, Chelsea Meloche, Tariq U Azam, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
JACC. Cardiooncology|May 2, 2022
Lifestyle and Cardiovascular Risk Factors Associated With Heart Failure Subtypes in Postmenopausal Breast Cancer SurvivorsKerryn W Reding, Richard K Cheng, Alexi Vasbinder, et al.
JACC. Cardiooncology|October 31, 2024
Life's Essential 8 and Incident Cardiovascular Disease in U.S. Women With Breast CancerElena Wadden, Alexi Vasbinder, Vidhushei Yogeswaran, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 27, 2024
Biomarkers of chronic inflammation and cognitive decline: A prospective observational studyBhavna A Guduguntla, Alexi Vasbinder, Elizabeth Anderson, et al.
Journal of Cardiovascular Translational Research|September 30, 2022
Chronic Oxidative Stress as a Marker of Long-term Radiation-Induced Cardiovascular Outcomes in Breast CancerAlexi Vasbinder, Richard K Cheng, Susan R Heckbert, et al.
The American Journal of Clinical Nutrition|December 31, 2020
Risk of metabolic syndrome and metabolic phenotypes in relation to biomarker-calibrated estimates of energy and protein intakes: an investigation from the Women's Health InitiativeAlexi Vasbinder, Lesley F Tinker, Marian L Neuhouser, et al.
The American Journal of Medicine|August 23, 2024
Statin Therapy, Inflammation, and Outcomes in Patients Hospitalized for COVID-19: A Prospective Multicenter Cohort StudyAnis Ismail, Husam R Shadid, Yiyuan Huang, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2026
Impact of <sup>18</sup> FDG-avidity and immunosuppression on idiopathic and genetic cardiomyopathiesShiva Tabaghi, Graham H Bevan, Stephen Hankinson, et al.
Journal of the American Heart Association|December 27, 2024
Inflammatory Markers and Measures of Cardiovascular Autonomic Neuropathy in Type 1 DiabetesLynn Ang, Sejal Gunaratnam, Yiyuan Huang, et al.
Journal of Cardiac Failure|March 2, 2026
Sotagliflozin, suPAR, and Cardiovascular Outcomes in Patients with Diabetes and Heart Failure: A SOLOIST-WHF Ancillary StudyAnis Ismail, Grace Erne, Alexi Vasbinder, et al.
Circulation. Cardiovascular Quality and Outcomes|October 4, 2022
Relationship Between Preexisting Cardiovascular Disease and Death and Cardiovascular Outcomes in Critically Ill Patients With COVID-19Alexi Vasbinder, Chelsea Meloche, Tariq U Azam, et al.
Pageof 5